Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
A simple and convenient method for the purification of Haemophilus Influenzae type b polysaccharide PRP
Darshan Gandhi; Rahul Patil; Manoj Joshi; Sunil Goel; Rajeev Dhere; Cyrus Poonawalla; Suresh BeriShow moreShow less
Serum Institute of India Pvt. Ltd., Pune, IndiaShow moreShow less
From discovery to innovation in animal health: meeting report of the second DIAH conference
Johannes Charlier; Laetitia Cicchelero; Beatrice Vos; Juerg Baggenstoss; Hervé Poulet; Dieter Vancraeynest; Sven ArnoutsShow moreShow less
Kreavet BV, Hendrik Mertensstraat 17, Kruibeke, 9150, Belgium; Ghent University, Salisburylaan 133, Merelbeke, 9820, Belgium; Stonehaven Cozmix Group, Schlossmühlestrasse 9, Frauenfeld, 8500, Switzerland; Boehringer-Ingelheim, 29 Avenue Tony Garnier, Lyon, 69007, France; Zoetis, Mercuriusstraat 20, Zaventem, 1930, BelgiumShow moreShow less
Assessing consequences of maternal immunization on fetal outcomes - A meeting report
Stephen Evans; Flor M. Munoz; Steve Black; Kathryn M. Edwards; Nick J. Andrews; Benjamin Atkins; Madhava Ram Balakrishnan; Marco Cavaleri; Hannah G. Davies; Alemayehu Duga; Janet A. Englund; Deshayne B. Fell; Delyth Jones; Kirsty Le Doare; Gwen Lemey; Shabir Madhi; Souad Mansouri; Solange Milolo Tshilumba; Jezid Miranda; Paulina Morales-Ruiz; Victoria Prudence Nambasa; Hanna Nohynek; Julien Nyombayire; Lidia Oostvogels; David Radley; Annette Regan; Anna C. Seale; Katerina Rok Song; James Southern; Jens-Ulrich Stegmann; Marc Baay; Pieter Neels; Frank VandendriesscheShow moreShow less
International Alliance of Biological Standardisation, Geneva, Switzerland; Departments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Global Vaccine Data Network Uniservices, Auckland, 1010, New Zealand; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK; Department Epidemiology Informatics, Murdoch Children's Research Institute, Parkville, Victoria, 3052, Australia; Pharmacovigilance Unit, World Health Organization, Geneva, Switzerland; EMA, Amsterdam, Netherlands; Centre for Neonatal and Paediatric Infection, City St George's, University of London, London, UK; London School of Hygiene & Tropical Medicine, London, UK; Department for Infection and Population Health, Institute for Global Health, University College London, UK; Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa, Ethiopia; Seattle Children's Research Institute and Department of Pediatrics, University of Washington, 4800 Sand Point Way NE, Seattle, WA, 98105, USA; Medical Evidence Development, Pfizer Inc., New York, USA; GSK, Stevenage, UK; Makerere University Johns Hopkins Research Collaboration (MUJHU), Kampala, Uganda; Global Health Institute (GHI), University of Antwerp, Antwerp, Belgium; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; BioNet, 19 Soi Udomsuk 37, Sukhumvit 103 Road, Bangjak, Prakanong, Bangkok, 10260, Thailand; Clinical Research and Immunization, Department of Tropical Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Cartagena, Zaragocilla Carrera 50 #24-63, Cartagena de Indias, 130014, Colombia; African Union Development Agency-NEPAD, Johannesburg, South Africa; Finnish Institute for Health and Welfare, Helsinki, Finland; Center for Family Health Research, P.O. Box 780, Kigali, Rwanda; MinervaX ApS, Frederiksberg, Denmark; Pfizer Vaccines, Pfizer Inc., Pearl River, NY, USA; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, 91101, USA; School of Nursing and Health Professions, University of San Francisco, Orange, CA, 92686, USA; Global Health Division, Gates Foundation, Seattle, USA; International Vaccine Institute, Seoul, Republic of Korea; South African Health Products Regulatory Authority (SAPHRA), Gauteng, South Africa; GSK, Wavre, Belgium; P95 Clinical & Epidemiology Services, Leuven, BelgiumShow moreShow less
Globally harmonized specifications: Implementing a patient-centric, enhanced control strategy – a meeting report
Yoji Sato; Andrew Chang; Cristiana Campa; Robin Levis; Masayo Takahashi; Phil Krause; Akiko Ishii-Watabe; Takahiro Yamaguchi; Horacio Pappa; Keiko Funato; Bénédicte Mouterde; Patrice Riou; Gerald Gellermann; Marisa K. Joubert; Vanessa Auquier; Jayda Siggers; Emmanuelle Charton; Anuradha Gupta; Minkyung Kim; Hiroko Shibata; Sirichair Krabesri; Sasiwimon Patasema; Jayoung Kim; Daisy Nie; Kaushik Sarkar; Shin Kawamata; Kok-Yew Ngew; Dean Smith; Shawn NovickShow moreShow less
National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki Ward, Kawasaki, Kanagawa, 210-9501, Japan; Novo Nordisk, 800 Scudders Mill Road Plainsboro, NJ, 08536, USA; GSK, Viale Dell'Agricoltura, 7, Verona, VR, 37135, Italy; Center for Biologics Evaluation and Research of the US Food and Drug Administration, 1401 Rockville Pike, Suite 200N/HFM-47, Rockville, MD, 20852-1448, USA; Riken Center for Developmental Biology, 2-2-3 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan; Asahi Kasei Pharma Corporation, 632-1, Izunokuni, Shizuoka, 410-2321, Japan; United States Pharmacopeia, 12601 Twinbrook Pkwy, Rockville, MD, 20852-1717, USA; GlaxoSmithKline, Akasaka Intercity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo, 107-0052, Japan; Sanofi, 1541, Avenue Marcel Merieux, Marcy L’Etoile, 69280, France; Novartis Pharma Services AG, Lichtstrasse 35, Basel, CH-4056, Switzerland; Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA; Union Chimique Belge, Allée de La Recherche, Brussels, 60 1070, Belgium; Health Canada, 1801B, Ottawa, Ontario, K1A 0K9, Canada; European Directorate for the Quality of Medicines & HealthCare, 7 Allée Kastner, CS 30026, Strasbourg, F-67081, France; Indian Pharmacopoeia Commission, Sector 23, Raj Nagar Ghaziabad, Uttar Pradesh, 201002, India; Thai Pharmacopeia, Institute of Thai Traditional Medicine, Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Nonthaburi, 11000, Thailand; Korean Pharmacopeia, 187, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea; Novartis Pharmaceuticals Corporation, 1 Health Plz, East Hanover, NJ, 07936, USA; Novo Nordisk A/S, Novo Allé, Bagsvaerd, 2880, Denmark; Cyto-Facto, Shimin Byoin Mae Bldg 3F, 2-1-11 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan; P95 Epidemiology and Pharmacovigilance, Koning Leopold III Laan 1, Leuven, 3001, Belgium; IABS, Rue de L’Est 8, Geneva, CH-1207, SwitzerlandShow moreShow less
Development and validation of a quantitative real-time PCR method for determination of residual host DNA in recombinant human C1 esterase inhibitor (rhC1INH)
Cong Cong; Xiaoping Yu; Tianfei Du; Yali Gao; Jiayao Tian; Chunyang Li; Lanjun LiuShow moreShow less
Chengdu Institute of Biological Products Co.,Ltd, Chengdu, Sichuan Province, 610023, ChinaShow moreShow less
Supporting 3Rs approaches in biologicals testing: responses from a survey of Manufacturers, Contract Research Organisations, National Control Laboratories and National Regulatory Authorities
Elliot Lilley; Sunil Goel; Robin Levis; Shajahan Shaid; Sarah Sheridan; Paul Stickings; Laura Viviani; Anthony HolmesShow moreShow less
NC3Rs, London, United Kingdom; Serum Institute of India, India; Food and Drug Administration, USA; GlaxoSmithKline, Germany; Merck, Glasgow, United Kingdom; Medicines and Healthcare Products Regulatory Agency, United Kingdom; SciEthiq, ItalyShow moreShow less
FAQ
How long does BIOLOGICALS take to review a manuscript?
As of 2026-11-19, CrushSCI has 15 complete review records for BIOLOGICALS. The fastest paper went from submission to acceptance in 6 days (Report of the international conference on animal testing replacement for vaccines: A one health view on global outlook and future strategy, received 2026-07-15, accepted 2026-07-21); the slowest took 258 days. The average is 90.2 days and the median is 79 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
